Gyre Therapeutics (GYRE) Current Taxes (2022 - 2026)

Gyre Therapeutics (GYRE) has 5 years of Current Taxes data on file, last reported at $3.1 million in Q1 2026.

• Current Taxes for Q1 2026 came in at $3.1 million, up 450.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.1 million (up 450.26% YoY), and the FY2025 annual result was $2.9 million, up 3.85% from the prior year.
• Current Taxes advanced to $3.1 million in Q1 2026 per GYRE's latest filing, from $2.9 million in the prior quarter.
• Over five years, Current Taxes peaked at $6.5 million in Q1 2024 and troughed at $569000.0 in Q1 2025.
• A 5-year average of $2.9 million and a median of $2.8 million in 2024 frame the typical range for Current Taxes.
• The sharpest annual moves came in 2025 and 2026: Current Taxes slumped 91.21% in 2025, then surged 450.26% in 2026.
• A 5-year view of Current Taxes shows it stood at $2.1 million in 2022, then surged by 140.55% to $5.1 million in 2023, then tumbled by 43.98% to $2.8 million in 2024, then rose by 3.85% to $2.9 million in 2025, then increased by 6.5% to $3.1 million in 2026.
• Business Quant data shows GYRE's Current Taxes at $3.1 million in Q1 2026, $2.9 million in Q4 2025, and $2.6 million in Q3 2025.